Literature DB >> 11908646

Characterization of mammalian receptors for lactoferrin.

Yasushi A Suzuki1, Bo Lönnerdal.   

Abstract

Lactoferrin (Lf) has been suggested to have several physiological functions. Specific binding of Lf, indicating the presence of Lf receptors (LfRs), has been observed in various types of mammalian cells such as lymphocytes, hepatocytes, and enterocytes. These LfRs are considered to function as a mediator for some of the functions of Lf. We here review current knowledge of mammalian LfRs characterized in different tissues. We also briefly present evidence for the existence of an LfR provided by our cloning of a human intestinal LfR (HLfR). The entire coding region of the HLfR was cloned by polymerase chain reaction (PCR), and a recombinant HLfR (rHLfR) was expressed in a baculovirus system. The rHLfR was purified by immobilized human Lf (HLf) affinity chromatography, indicating that the rHLfR retained the capacity to bind HLf. The gene was expressed at high levels in fetal small intestine and in adult heart but at lower levels in Caco-2 cells. In summary, we demonstrate the presence of a unique receptor-mediated mechanism for Lf, functioning in the small intestine of the newborn infant and possibly in other tissues of human adults.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11908646     DOI: 10.1139/o01-228

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  14 in total

1.  Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.

Authors:  William C Adams; Emily Bond; Menzo J E Havenga; Lennart Holterman; Jaap Goudsmit; Gunilla B Karlsson Hedestam; Richard A Koup; Karin Loré
Journal:  J Gen Virol       Date:  2009-03-12       Impact factor: 3.891

Review 2.  Lactoferrin--a novel bone growth factor.

Authors:  Dorit Naot; Andrew Grey; Ian R Reid; Jillian Cornish
Journal:  Clin Med Res       Date:  2005-05

Review 3.  The role of talactoferrin alpha in the treatment of non-small cell lung cancer.

Authors:  Ronan J Kelly; Giuseppe Giaccone
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

4.  A complex of lactoferrin with monophosphoryl lipid A is an efficient adjuvant of the humoral and cellular immune response in mice.

Authors:  Grzegorz Chodaczek; Michal Zimecki; Jolanta Lukasiewicz; Czesław Lugowski
Journal:  Med Microbiol Immunol       Date:  2006-07-13       Impact factor: 3.402

5.  Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes.

Authors:  Shen-An Hwang; Katarzyna M Wilk; Yogesh A Bangale; Marian L Kruzel; Jeffrey K Actor
Journal:  Med Microbiol Immunol       Date:  2007-03-22       Impact factor: 3.402

6.  Protein-functionalized PLGA nanoparticles of lamotrigine for neuropathic pain management.

Authors:  Jigar Lalani; Sushilkumar Patil; Atul Kolate; Riddhi Lalani; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2014-10-30       Impact factor: 3.246

7.  Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo.

Authors:  Jeffrey S Wolf; Guoyan Li; Atul Varadhachary; Karel Petrak; Mark Schneyer; Daqing Li; Julina Ongkasuwan; Xiaoyu Zhang; Rodney J Taylor; Scott E Strome; Bert W O'Malley
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

8.  Protein multifunctionality: principles and mechanisms.

Authors:  Joseph Z Zaretsky; Daniel H Wreschner
Journal:  Transl Oncogenomics       Date:  2008-05-15

9.  Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women.

Authors:  S Bharadwaj; A G T Naidu; G V Betageri; N V Prasadarao; A S Naidu
Journal:  Osteoporos Int       Date:  2009-01-27       Impact factor: 4.507

10.  Effect of lactoferrin protein on red blood cells and macrophages: mechanism of parasite-host interaction.

Authors:  Namrata Anand; Rupinder K Kanwar; Mohan Lal Dubey; R K Vahishta; Rakesh Sehgal; Anita K Verma; Jagat R Kanwar
Journal:  Drug Des Devel Ther       Date:  2015-07-27       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.